Insulet (NASDAQ: PODD)
$266.30
(3.7%)
$9.45
Price as of January 3, 2025, 4:00 p.m. ET
Insulet Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Insulet Company Info
Insulet makes the leading wearable, tubeless insulin pump for diabetics.
News & Analysis
The Fool has written over 100 articles on Insulet.
Featured Article
Why Insulet Stock Was Zooming Higher This Week
The company had encouraging news to impart about its leading insulin pump.
Eric Volkman | Aug 30, 2024
Featured Article
Why Shares of Insulet Dropped This Week
Positive news regarding diabetes therapy Ozempic worried investors.
Jim Halley | Oct 12, 2023
Why Insulet Stock Is Sinking Today
Keith Speights | Sep 7, 2023
Comments from Insulet's CEO at a major healthcare conference rattled investors.
Is It Time to Buy the S&P 500's 3 Worst-Performing August Stocks?
Jeremy Bowman | Sep 7, 2023
The S&P 500 had a rare decline last month.
Why Insulet Stock Rocked the Market Today
Eric Volkman | Aug 30, 2023
The company's leader signals a giant vote of confidence in its future.
3 Growth Stocks That Have Delivered 10X Returns Over the Past Decade
David Jagielski | Feb 14, 2023
Are these stocks still good buys today?
2 Best Medical Device Stocks for 2023
George Budwell | Dec 8, 2022
Insulet and Conmed ought to be medtech's shining stars in 2023.
Why Insulet Stock Is Skyrocketing Today
Keith Speights | Nov 4, 2022
Investors are cheering the company's strong Q3 results.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.